Ofatumumab

Start date for training is Jan 6. Home study and then 2 weeks in NJ beginning Feb 10. You will have to do Best Start training (welcome to the company for a few days) at some point in there, probably Jan 6.

Offers are supposed to go out by the end of the second week in December.

 

Thank you for the info. Recruiter does not reply to emails, so it is hard to know what is going on...

 

Very clear you haven't sold in MS. And the fact you think Neuro is an easy to see specialty (especially those that specialize in MS) validates that you have no clue what you are talking about. That is why reps that work easier specialties or really non specialties (like cardio, psych, derm, endo, etc) have a hard time making the jump.

Rumor is with the stock grants vesting on the Cosentyx team many are thinking of coming over to MS. Most if not all will struggle.

 

Well then they will fit right in with the new leadership - none of which have MS experience and have no respect for what it takes to be successful. Total train wreck over here already.

 

How do you think this drug will do against Ocrevus?

 

Genentech hired an older “more experienced” sales force that luckily until now has had a product that basically sold itself. Our customers haven’t been impressed- I like our chances.

 

Many offices will want to keep infusions most.

 

Most offices don't do infusions...and patients will prefer not to do infusions. Do you even work in MS?

 

We are not doctors. This job is just not that difficult! Maybe it is for you, and that’s why you think others will struggle. Maybe your ego is just too fragile to come to terms with reality. Your access probably sucks because you are inept at relationship building and leveraging those relationships. If you think that the disease state and/or number and/or competitors and/or coverage process are just SO difficult to learn and SO complex, then I’m sorry for you, because you are the one who will struggle if you ever go into any number of other specialties. It sounds like you will undoubtedly struggle with the relationship and access part, too.

And, yes, I have sold in MS, and it wasn’t that long ago.

 

Yes you are right I don't have "MD" after my name. But its apparent the difference between you and me is that my Dr.'s do respect me and value my knowledge of the entire market of MS. At the end of the day I'm more up to date on the in and outs of MS than the majority of my Dr.'s- they in fact rely on me to help them navigate an increasingly difficult landscape.

So although you "sold" in MS I'm quite sure you weren't very good. Consultative selling is what works in this arena and if you aren't more of an expert than the Dr.'s you are calling on you aren't adding value. MS is a very complex disease state its clearly not for everyone. Which is why we are paid as well as we are. Which is why the majority of pharmaceutical reps can't handle what we do day in and day out. We make a huge difference in patients lives and in helping Dr.'s understand where everything "fits".

 

Bro get over yourself. I can teach any rep MS in 3 weeks. Clowns like this think they were born an MS rep. You started out as primary care like everyone else. I have been in MS for 20 years it ain't that hard.

 

you are the clown and obviously not in MS. Probably cardio primary care. Big difference chief.

 

What is the deal with offers? I guess if I have not heard anything that means I didn’t get it? I called recruiter and no call back? Did they push hiring back? I thought everything had to be turned in by 20 th of December? To start on the 6 th? Anyone with nice comments can reply. Thank you.

 

I launched Betaseron so well before you even knew what MS was. So get over yourself you are not that good. Ofa will fail anyway it's Novartis. HAHAHA. We are not even worried about it docs love Ocrevus.

 

you should be worried...and I would be even more worried about your upcoming ecosystems and the number of reps in MS getting replaced by reps from Heme. Your company is a disaster and your product not as good.

 

You clowns screwed up Extavia,Gilenya and now Mayzent. What makes you think you have any shot beating a real biotech company. Ocrevus is kicking ass you got no shot quit now.

 

Teams are 90% full will be expanding the PSC, MSL and FRM teams for support soon.

 

stfu
You ass hats at Genentech are screwing things up nicely all on your own. Not to mention the cuts to 340b reimbursement in 2020 and the CMS change to reimbursement in regulated space is going to take the profit out of infusions. You all know ofatumamab is a huge threat that’s why you have a sub Q trial enrolling now......you sound like a pissed off whiner who obviously didn’t get a call back.

 

Ok clown nobody wants to work for Novartis. You failed with the last 3 MS drugs this will be no different. You failed with the migraine drug. Your company is a joke Mr. MS expert. Nobody is leaving Genentech for Ofa.

 

definitely not true. And people are leaving Genentech in droves. Remember your asshat leader that said you have more work than people....then announced plans to lay-off 60-70% of salesforce ( including your ms salesforce replacing you with reps from oncology)...and yet now his statement is true because no one wants to work in your “ecosystems”. Genentech is a sad case study of bad culture turning a once great place into a dumpster fire.